Work

Figure S6 from Inhibition of BCL2 Family Members Increases the Efficacy of Copper Chelation in BRAFV600E-Driven Melanoma

Year: 2023

Type: other

Abstract: Supplemental Figure S6. TTM sensitizes vemurafenib-resistant BRAFV600E-positive melanoma cells to a BCL2 protein inhibitor.

DOI: 10.1158/0008-5472.24895327.v1

Authors: Ye-Jin Kim, Tiffany Tsang, Grace R. Anderson, Jessica M. Posimo, Donita C. Brady

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4390100908

Cites:

Cited by:

Related to: 10